Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 4 | 2013 | 760 | 0.490 |
Why?
|
| Patient Admission | 4 | 2023 | 165 | 0.460 |
Why?
|
| Bronchiolitis, Viral | 3 | 2011 | 29 | 0.450 |
Why?
|
| Hypotonic Solutions | 1 | 2014 | 12 | 0.430 |
Why?
|
| Isotonic Solutions | 1 | 2014 | 34 | 0.430 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2011 | 357 | 0.430 |
Why?
|
| Child, Hospitalized | 1 | 2014 | 78 | 0.400 |
Why?
|
| Hyponatremia | 1 | 2014 | 71 | 0.400 |
Why?
|
| Fluid Therapy | 1 | 2014 | 145 | 0.390 |
Why?
|
| Triage | 3 | 2023 | 143 | 0.330 |
Why?
|
| Apnea | 1 | 2009 | 27 | 0.310 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2019 | 472 | 0.260 |
Why?
|
| Critical Care | 3 | 2022 | 659 | 0.240 |
Why?
|
| Patient Discharge | 2 | 2019 | 461 | 0.240 |
Why?
|
| Nystagmus, Congenital | 1 | 2004 | 1 | 0.230 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2004 | 2 | 0.230 |
Why?
|
| Bronchiolitis | 3 | 2015 | 122 | 0.230 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2026 | 133 | 0.230 |
Why?
|
| B7-H1 Antigen | 1 | 2026 | 125 | 0.220 |
Why?
|
| Oculomotor Muscles | 1 | 2004 | 58 | 0.220 |
Why?
|
| Infant, Premature | 1 | 2009 | 822 | 0.210 |
Why?
|
| Hospitalization | 5 | 2023 | 1811 | 0.210 |
Why?
|
| Pneumonia | 2 | 2018 | 331 | 0.190 |
Why?
|
| Hospitalists | 1 | 2022 | 45 | 0.180 |
Why?
|
| Pediatrics | 2 | 2022 | 1205 | 0.170 |
Why?
|
| Hospitals | 1 | 2023 | 411 | 0.160 |
Why?
|
| Length of Stay | 2 | 2015 | 1318 | 0.150 |
Why?
|
| Child | 12 | 2023 | 25112 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2026 | 876 | 0.140 |
Why?
|
| Community-Acquired Infections | 2 | 2018 | 249 | 0.130 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 143 | 0.120 |
Why?
|
| Period Circadian Proteins | 1 | 2015 | 25 | 0.120 |
Why?
|
| United States | 6 | 2026 | 11187 | 0.120 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 100 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 2926 | 0.110 |
Why?
|
| Oximetry | 1 | 2015 | 174 | 0.110 |
Why?
|
| Infant | 10 | 2019 | 12803 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 370 | 0.100 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2013 | 13 | 0.100 |
Why?
|
| Humans | 21 | 2026 | 126134 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2010 | 56 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2014 | 3422 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 523 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 689 | 0.100 |
Why?
|
| Child, Preschool | 7 | 2018 | 14375 | 0.090 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 171 | 0.090 |
Why?
|
| Risk | 1 | 2014 | 723 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 736 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 376 | 0.090 |
Why?
|
| Neoplasms | 1 | 2026 | 2841 | 0.090 |
Why?
|
| Cohort Studies | 4 | 2018 | 4894 | 0.080 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 21 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2015 | 709 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 823 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 760 | 0.080 |
Why?
|
| Vocal Cords | 1 | 2009 | 60 | 0.070 |
Why?
|
| Forced Expiratory Volume | 1 | 2009 | 164 | 0.070 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2009 | 73 | 0.070 |
Why?
|
| Environment | 1 | 2009 | 146 | 0.070 |
Why?
|
| Cough | 1 | 2009 | 93 | 0.070 |
Why?
|
| Bacterial Infections | 1 | 2011 | 319 | 0.070 |
Why?
|
| Delphi Technique | 2 | 2019 | 235 | 0.070 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2009 | 119 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 914 | 0.070 |
Why?
|
| Environmental Exposure | 1 | 2009 | 211 | 0.070 |
Why?
|
| Cost of Illness | 1 | 2009 | 282 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 332 | 0.070 |
Why?
|
| Allergens | 1 | 2009 | 275 | 0.070 |
Why?
|
| Quality of Life | 2 | 2013 | 2014 | 0.060 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 335 | 0.060 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2026 | 38 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2509 | 0.060 |
Why?
|
| Adolescent | 6 | 2023 | 19986 | 0.060 |
Why?
|
| Male | 11 | 2026 | 62225 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 428 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 1239 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2009 | 1475 | 0.060 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2005 | 9 | 0.060 |
Why?
|
| Female | 11 | 2026 | 68037 | 0.060 |
Why?
|
| Head Movements | 1 | 2004 | 17 | 0.060 |
Why?
|
| Eye Movements | 1 | 2004 | 56 | 0.050 |
Why?
|
| Posture | 1 | 2004 | 133 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2004 | 250 | 0.050 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2004 | 70 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1823 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2004 | 64 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2004 | 121 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2015 | 4472 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2011 | 8381 | 0.050 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 1019 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2023 | 63 | 0.050 |
Why?
|
| Prevalence | 1 | 2009 | 2571 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1229 | 0.050 |
Why?
|
| Syndrome | 1 | 2004 | 1114 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2004 | 520 | 0.050 |
Why?
|
| Incidence | 1 | 2009 | 3193 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 276 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2026 | 1107 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2004 | 644 | 0.040 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2001 | 149 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2009 | 5107 | 0.040 |
Why?
|
| Inservice Training | 1 | 2019 | 55 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 6178 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2019 | 142 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2005 | 675 | 0.040 |
Why?
|
| Patient Transfer | 1 | 2019 | 107 | 0.040 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 31 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2018 | 51 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2019 | 16831 | 0.030 |
Why?
|
| Oxygen | 2 | 2015 | 544 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 656 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Risk Factors | 1 | 2009 | 10374 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2019 | 547 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2015 | 167 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 193 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 236 | 0.030 |
Why?
|
| Sirolimus | 1 | 2015 | 224 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2005 | 13 | 0.030 |
Why?
|
| Chemokine CCL3 | 2 | 2005 | 16 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 415 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 777 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 615 | 0.020 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 111 | 0.020 |
Why?
|
| Breath Tests | 1 | 2013 | 182 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2013 | 209 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1026 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1540 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 1187 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 520 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 2011 | 96 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1739 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 764 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1294 | 0.020 |
Why?
|
| Aged | 1 | 2026 | 20078 | 0.020 |
Why?
|
| Caregivers | 1 | 2013 | 553 | 0.020 |
Why?
|
| Bacteremia | 1 | 2011 | 419 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2011 | 309 | 0.020 |
Why?
|
| Middle Aged | 1 | 2026 | 27402 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 52 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2004 | 21 | 0.010 |
Why?
|
| Adult | 1 | 2004 | 30314 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 3895 | 0.010 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2004 | 219 | 0.010 |
Why?
|
| Nasopharynx | 1 | 2001 | 86 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2001 | 186 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2001 | 155 | 0.010 |
Why?
|
| Cytokines | 1 | 2001 | 1317 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 33230 | 0.010 |
Why?
|